 Christopher Schneck
Concepts (148)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Bipolar Disorder | 32 | 2024 | 263 | 6.020 |
Why?
| | Depressive Disorder, Major | 9 | 2023 | 365 | 1.990 |
Why?
| | Family Therapy | 19 | 2023 | 65 | 1.980 |
Why?
| | Affect | 12 | 2023 | 292 | 1.230 |
Why?
| | Telemedicine | 7 | 2025 | 862 | 1.070 |
Why?
| | Mental Health Services | 5 | 2025 | 421 | 0.850 |
Why?
| | Mood Disorders | 6 | 2025 | 133 | 0.690 |
Why?
| | Estrogen Antagonists | 1 | 2020 | 45 | 0.670 |
Why?
| | Tamoxifen | 1 | 2020 | 202 | 0.630 |
Why?
| | Behavioral Symptoms | 2 | 2017 | 42 | 0.630 |
Why?
| | Antineoplastic Agents, Hormonal | 1 | 2020 | 161 | 0.620 |
Why?
| | Antipsychotic Agents | 8 | 2017 | 197 | 0.430 |
Why?
| | Cognition | 1 | 2020 | 1157 | 0.380 |
Why?
| | Attention Deficit Disorder with Hyperactivity | 4 | 2021 | 418 | 0.370 |
Why?
| | Adolescent | 26 | 2023 | 21574 | 0.340 |
Why?
| | Psychotherapy, Brief | 3 | 2020 | 34 | 0.330 |
Why?
| | Algorithms | 2 | 2017 | 1704 | 0.330 |
Why?
| | Anxiety Disorders | 5 | 2021 | 377 | 0.320 |
Why?
| | Humans | 48 | 2025 | 137782 | 0.300 |
Why?
| | Depressive Disorder | 4 | 2011 | 379 | 0.290 |
Why?
| | Family Conflict | 4 | 2022 | 41 | 0.280 |
Why?
| | Psychiatric Status Rating Scales | 5 | 2017 | 547 | 0.270 |
Why?
| | Valproic Acid | 2 | 2006 | 48 | 0.250 |
Why?
| | Depression | 5 | 2023 | 1408 | 0.250 |
Why?
| | Mental Health | 3 | 2020 | 729 | 0.230 |
Why?
| | Treatment Outcome | 14 | 2023 | 10837 | 0.220 |
Why?
| | Female | 26 | 2025 | 73465 | 0.220 |
Why?
| | Antimanic Agents | 2 | 2009 | 18 | 0.220 |
Why?
| | Smartphone | 1 | 2025 | 91 | 0.220 |
Why?
| | Depressive Disorder, Treatment-Resistant | 1 | 2023 | 10 | 0.210 |
Why?
| | Anhedonia | 1 | 2023 | 13 | 0.210 |
Why?
| | Pandemics | 3 | 2020 | 1639 | 0.210 |
Why?
| | Anticipation, Psychological | 1 | 2023 | 18 | 0.200 |
Why?
| | Family Relations | 3 | 2020 | 91 | 0.200 |
Why?
| | Ketamine | 1 | 2023 | 94 | 0.200 |
Why?
| | Sexual Dysfunctions, Psychological | 1 | 2002 | 34 | 0.190 |
Why?
| | Comorbidity | 4 | 2019 | 1623 | 0.190 |
Why?
| | Child | 11 | 2022 | 21989 | 0.190 |
Why?
| | Patient Education as Topic | 5 | 2017 | 766 | 0.190 |
Why?
| | Age of Onset | 4 | 2011 | 520 | 0.180 |
Why?
| | Amygdala | 1 | 2023 | 191 | 0.180 |
Why?
| | Nucleus Accumbens | 1 | 2023 | 138 | 0.180 |
Why?
| | Antidepressive Agents | 3 | 2009 | 236 | 0.180 |
Why?
| | Language | 1 | 2024 | 294 | 0.170 |
Why?
| | Clinical Decision-Making | 1 | 2024 | 326 | 0.170 |
Why?
| | Reward | 1 | 2023 | 245 | 0.170 |
Why?
| | Decision Support Systems, Clinical | 1 | 2024 | 236 | 0.170 |
Why?
| | Male | 22 | 2025 | 67906 | 0.160 |
Why?
| | Feedback | 1 | 2020 | 173 | 0.160 |
Why?
| | Combined Modality Therapy | 5 | 2023 | 1236 | 0.160 |
Why?
| | Ericales | 1 | 1998 | 2 | 0.150 |
Why?
| | Panic Disorder | 1 | 1998 | 24 | 0.150 |
Why?
| | Attention Deficit and Disruptive Behavior Disorders | 1 | 2018 | 62 | 0.150 |
Why?
| | Outpatients | 2 | 2020 | 397 | 0.150 |
Why?
| | Phytotherapy | 1 | 1998 | 83 | 0.140 |
Why?
| | House Calls | 1 | 2019 | 138 | 0.140 |
Why?
| | Psychiatry | 1 | 2020 | 180 | 0.140 |
Why?
| | Suicidal Ideation | 2 | 2020 | 534 | 0.140 |
Why?
| | Diagnostic and Statistical Manual of Mental Disorders | 2 | 2009 | 243 | 0.140 |
Why?
| | Kidney Failure, Chronic | 1 | 2023 | 570 | 0.130 |
Why?
| | Kidney Transplantation | 1 | 2023 | 709 | 0.130 |
Why?
| | Ambulatory Care | 1 | 2020 | 546 | 0.130 |
Why?
| | Physician-Patient Relations | 1 | 2020 | 558 | 0.120 |
Why?
| | Mental Disorders | 2 | 2025 | 1077 | 0.120 |
Why?
| | Movement Disorders | 1 | 2015 | 58 | 0.110 |
Why?
| | Psychotropic Drugs | 4 | 2020 | 68 | 0.110 |
Why?
| | Irritable Mood | 2 | 2019 | 50 | 0.110 |
Why?
| | Stress, Psychological | 1 | 2023 | 1108 | 0.110 |
Why?
| | Patient Acceptance of Health Care | 1 | 2020 | 807 | 0.110 |
Why?
| | Adult | 7 | 2025 | 38023 | 0.110 |
Why?
| | Expressed Emotion | 2 | 2013 | 17 | 0.100 |
Why?
| | Risk Factors | 5 | 2013 | 10407 | 0.100 |
Why?
| | Anti-HIV Agents | 1 | 2019 | 778 | 0.100 |
Why?
| | Diagnosis, Differential | 2 | 2009 | 1483 | 0.100 |
Why?
| | Surveys and Questionnaires | 2 | 2025 | 5793 | 0.090 |
Why?
| | Psychotherapy | 2 | 2019 | 167 | 0.090 |
Why?
| | Risk Assessment | 2 | 2017 | 3461 | 0.090 |
Why?
| | Sex Factors | 2 | 2009 | 2077 | 0.090 |
Why?
| | Severity of Illness Index | 3 | 2011 | 2836 | 0.080 |
Why?
| | Retrospective Studies | 4 | 2020 | 15682 | 0.080 |
Why?
| | Euphoria | 1 | 2009 | 3 | 0.080 |
Why?
| | Hostility | 1 | 2009 | 15 | 0.080 |
Why?
| | Quality of Life | 2 | 2019 | 2894 | 0.070 |
Why?
| | Phenotype | 1 | 2017 | 3196 | 0.070 |
Why?
| | Disease Progression | 2 | 2020 | 2760 | 0.070 |
Why?
| | Thinking | 1 | 2009 | 65 | 0.070 |
Why?
| | Problem Solving | 3 | 2017 | 152 | 0.070 |
Why?
| | Anticonvulsants | 2 | 2008 | 217 | 0.070 |
Why?
| | Drug Therapy, Combination | 2 | 2009 | 1067 | 0.060 |
Why?
| | Secondary Prevention | 1 | 2008 | 234 | 0.060 |
Why?
| | Lithium Compounds | 1 | 2006 | 12 | 0.060 |
Why?
| | Models, Psychological | 1 | 2008 | 301 | 0.060 |
Why?
| | Cohort Studies | 2 | 2008 | 5750 | 0.060 |
Why?
| | Patient Care Management | 1 | 2006 | 57 | 0.060 |
Why?
| | HIV Infections | 1 | 2019 | 2837 | 0.060 |
Why?
| | Diagnosis, Dual (Psychiatry) | 1 | 2004 | 36 | 0.060 |
Why?
| | Critical Pathways | 1 | 2006 | 96 | 0.060 |
Why?
| | Prospective Studies | 2 | 2008 | 7623 | 0.060 |
Why?
| | Motor Activity | 1 | 2009 | 718 | 0.050 |
Why?
| | Lithium | 1 | 2023 | 43 | 0.050 |
Why?
| | Anxiety | 2 | 2021 | 1043 | 0.050 |
Why?
| | Infusions, Intravenous | 1 | 2023 | 413 | 0.050 |
Why?
| | Communication | 3 | 2017 | 879 | 0.050 |
Why?
| | Insurance Coverage | 1 | 2023 | 230 | 0.050 |
Why?
| | Follow-Up Studies | 2 | 2009 | 5136 | 0.050 |
Why?
| | Cross-Sectional Studies | 2 | 2021 | 5478 | 0.040 |
Why?
| | Precision Medicine | 1 | 2025 | 433 | 0.040 |
Why?
| | Waiting Lists | 1 | 2023 | 266 | 0.040 |
Why?
| | Living Donors | 1 | 2023 | 296 | 0.040 |
Why?
| | Age Factors | 1 | 2008 | 3305 | 0.040 |
Why?
| | Middle Aged | 4 | 2025 | 33554 | 0.040 |
Why?
| | Family Health | 2 | 2013 | 196 | 0.040 |
Why?
| | Psychomotor Agitation | 1 | 2019 | 71 | 0.040 |
Why?
| | Food, Organic | 1 | 1998 | 2 | 0.040 |
Why?
| | Neuropsychological Tests | 1 | 2023 | 1025 | 0.040 |
Why?
| | Sertraline | 1 | 1998 | 29 | 0.040 |
Why?
| | Organophosphates | 1 | 2019 | 134 | 0.040 |
Why?
| | Executive Function | 1 | 2023 | 451 | 0.040 |
Why?
| | Animals | 1 | 2020 | 36951 | 0.040 |
Why?
| | Chromatography, Liquid | 1 | 2019 | 433 | 0.030 |
Why?
| | Viral Load | 1 | 2019 | 469 | 0.030 |
Why?
| | Adenine | 1 | 2019 | 271 | 0.030 |
Why?
| | Prevalence | 1 | 2004 | 2734 | 0.030 |
Why?
| | Prodromal Symptoms | 1 | 2017 | 15 | 0.030 |
Why?
| | Longitudinal Studies | 2 | 2018 | 2860 | 0.030 |
Why?
| | Patient Outcome Assessment | 1 | 2018 | 131 | 0.030 |
Why?
| | Feasibility Studies | 1 | 2020 | 963 | 0.030 |
Why?
| | Tandem Mass Spectrometry | 1 | 2019 | 532 | 0.030 |
Why?
| | Patient Compliance | 2 | 2011 | 581 | 0.030 |
Why?
| | Regression Analysis | 1 | 2018 | 1024 | 0.030 |
Why?
| | Substance-Related Disorders | 1 | 2004 | 1083 | 0.030 |
Why?
| | Mothers | 1 | 2021 | 759 | 0.030 |
Why?
| | Videoconferencing | 1 | 2015 | 66 | 0.030 |
Why?
| | Pilot Projects | 1 | 2020 | 1713 | 0.030 |
Why?
| | Emotions | 1 | 2018 | 551 | 0.020 |
Why?
| | Early Medical Intervention | 1 | 2013 | 57 | 0.020 |
Why?
| | Research | 1 | 2015 | 451 | 0.020 |
Why?
| | Practice Patterns, Physicians' | 1 | 2020 | 1313 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2019 | 3290 | 0.020 |
Why?
| | Parents | 1 | 2020 | 1350 | 0.020 |
Why?
| | Education | 1 | 2009 | 108 | 0.020 |
Why?
| | Convalescence | 1 | 2008 | 17 | 0.020 |
Why?
| | Biomarkers | 1 | 2019 | 4154 | 0.020 |
Why?
| | Young Adult | 1 | 2023 | 13240 | 0.020 |
Why?
| | Recurrence | 1 | 2008 | 1061 | 0.010 |
Why?
| | Time Factors | 1 | 2014 | 6834 | 0.010 |
Why?
| | Genetic Predisposition to Disease | 1 | 2011 | 2427 | 0.010 |
Why?
| | Adolescent Behavior | 1 | 2004 | 531 | 0.010 |
Why?
|
|
Schneck's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|